These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 576372)

  • 21. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
    J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
    Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
    J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galactorrhea-amenorrhea syndromes: etiology and treatment.
    Spark RF; Pallotta J; Naftolin F; Clemens R
    Ann Intern Med; 1976 May; 84(5):532-7. PubMed ID: 945033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
    Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour.
    Perry-Keene DA; Warne GL; Martin FI
    Med J Aust; 1976 Oct; 2(16):602-4. PubMed ID: 1036755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.
    MacGregor C; Maldonado D; Canales ES; Soria J; Zárate A
    Acta Obstet Gynecol Scand; 1977; 56(4):333-6. PubMed ID: 414510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of ovulation in patients with normoprolactinemic amenorrhea by combined therapy with bromocriptine and clomiphene.
    Koike K; Aono T; Miyake A; Tsutsumi H; Matsumoto K; Kurachi K
    Fertil Steril; 1981 Feb; 35(2):138-41. PubMed ID: 6781935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperprolactinemia and hypogonadism in the human female.
    Rolland R; Corbey RS
    Eur J Obstet Gynecol Reprod Biol; 1977; 7(5):337-48. PubMed ID: 400856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperprolactinaemic amenorrhoea in Hong Kong.
    Tang LC; Sung ML; Ma HK
    Aust N Z J Obstet Gynaecol; 1983 Aug; 23(3):165-9. PubMed ID: 6580885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
    Rjosk HK; Werder K; Fahlbusch R
    Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):575-87. PubMed ID: 986336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
    Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
    Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.
    Kleinberg DL; Noel GL; Frantz AG
    N Engl J Med; 1977 Mar; 296(11):589-600. PubMed ID: 840242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
    Aono T; Shioji T; Kohno M; Ueda G; Kurachi K
    Fertil Steril; 1976 Mar; 27(3):341-4. PubMed ID: 943332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hyperprolactinemic amenorrhea by intermittent administration of bromocryptine (CB 154).
    Polatti E; Bolis PF; Ravagni-Probizer MF; Baruffini A; Cavalleri A
    Am J Obstet Gynecol; 1978 Aug; 131(7):792-6. PubMed ID: 567429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.
    Tolis G; Laliberté R; Guyda H; Naftolin F
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1197-9. PubMed ID: 559690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin-secreting pituitary adenomas in women. II. Menstrual function, pituitary reserves, and prolactin production following microsurgical removal.
    Keye WR; Chang RJ; Monroe SE; Wilson CB; Jaffe RB
    Am J Obstet Gynecol; 1979 Jun; 134(4):360-5. PubMed ID: 222148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of menstruation with bromocriptine.
    Hahn L
    Am J Obstet Gynecol; 1978 Jan; 130(1):112-3. PubMed ID: 619640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of triiodothyronine treatment on prolactin secretion in patients with amenorrhea-galactorrhea.
    Aono T; Shioji T; Miyai K; Onishi T; Kurachi K
    J Clin Endocrinol Metab; 1977 Jan; 44(1):8-14. PubMed ID: 401825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.